GRZAN Medical Device Registration Services for Sri Lanka

1. Key takeaways

GRZAN delivers the complete service chain for medical device registration in Sri Lanka. The chain maps strictly onto the regulatory requirements: classification determination (general devices Class I–III / IVD Class A–D / listed devices) → appointment of a local MAH → preparation of the consolidated dossier (FMSA + PRD, or PRD only) → coordination of the Sample Import Licence (SIL) and testing → follow-up on acceptance and fee payment → post-market vigilance and 5-year renewal management. Because every step in the chain is anchored to a published rule, the client can see at any moment which regulatory requirement the current work item satisfies, and no stage of the project depends on informal practice.

This page presents the service in the form clients actually use it: the stage table first, so the regulatory anchor of each step is visible; then the three structural features of the Sri Lankan market that shape every schedule; and finally the step sequence with its deliverables. The closing checklist mirrors the service chain, allowing a client or an internal project reviewer to verify that each element of a project file exists before submission week arrives.

2. Legal basis

Each service stage is paired below with its governing source and, where one exists, its document number. The numbers are quoted exactly as published by NMRA, so the table can double as a citation reference in correspondence and submission cover letters.

3. Expert insights

Insight one: Sri Lankan projects have three hard gates. (1) A local MAH must be appointed (required by the rules); (2) the consolidated dossier is mandatory (compulsory for new applications since August 2025); (3) the submission window is only Tuesday 9:00–15:00 each week. These three conditions form the scheduling skeleton of every project. Everything else can be parallelised — documents can be drafted while the MAH appointment is finalised, testing can be arranged while the dossier is assembled — but the gates are sequential facts: no MAH, no submission; no consolidated dossier, no acceptance; no Tuesday slot, no physical filing. Project plans that treat any of the three as flexible discover the inflexibility at the moment it is most expensive.

Insight two: classification is the first fork in the road. General devices and IVDs follow two separate naming systems, and there is a third category of listed devices. If the classification is wrong, four things go wrong at once: the pathway, the dossier, the timeline and the fees. This is why the classification letter forms — F-MDR-044, F-MDR-043 and F-MDR-042 — occupy a full row of the service chain: the determination is not an internal judgement to be corrected later, but a documented confirmation with its own official forms. In practice we obtain the written classification confirmation before any dossier drafting begins. Time spent on classification at the start is repaid by avoiding a redirect halfway through preparation.

Insight three: the three exclusion conditions of the low-risk pathway must be checked item by item. The product must simultaneously be non-sterile, non-active and without a measuring function, and it must appear in the GL-037 Annex 1 list, which may itself be updated. The pathway is attractive but conditional, and both sets of conditions are verified against the current text rather than the text as remembered. A product checked against an outdated Annex 1 risks being prepared for a lane it no longer qualifies for, so the list is re-pulled at project start and re-checked before submission. The same discipline applies to the monthly fee table, since fees float with the month of submission.

4. Practical recommendations

GRZAN advises clients to advance their Sri Lankan project in a three-step sequence: step one, classification and qualification diagnosis (determine the device class and listed-device eligibility, inventory reference-country approvals, and confirm the MAH arrangement); step two, document preparation (technical documentation, quality certificates, and trilingual labelling and PIL); step three, submission and subsequent management (online form plus Tuesday window filing, payment and receipt of the dossier number, sample import and testing, post-market vigilance and renewal scheduling). Each step carries defined deliverables, so the client can judge progress at any time against documents delivered rather than assurances given. The sequence is also deliberately ordered by dependency: no document work begins before the pathway is fixed, and no submission is scheduled before the deliverables of step two are verified complete, because a rejected Tuesday slot cannot be recovered until the following week. The steps, their deliverables and their regulatory anchors therefore read as one continuous chain from first enquiry to renewal.

5. Verification checklist

• □ Classification determination completed (including the listed-device judgement)
• □ Local MAH appointed and LOA signed
• □ Dossier path determined (FMSA + PRD / PRD only)
• □ Technical documentation, quality certificates and trilingual labelling completed
• □ Online form completed and submitted at the Tuesday window
• □ Fee paid and dossier number obtained
• □ Sample import and testing arrangements scheduled
• □ Post-market vigilance and 5-year renewal plan established

Regulatory information verified as of 28 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Sri Lanka. Our team prepares dossiers to NMRA expectations, manages submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com